Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)

Summary

This trial will the efficacy of KM-819 compared to placebo in subjects with MSA for slowing the progression of MSA.

Timeline

Start

2023-02-27

Primary completion

2024-08-19

Completion

2024-08-19

Outcome

Outcome not reported

Stopped: “Sponsor has decided to withdraw the study due to safety issue and re-initiate with a new clinical study”

Drugs

Indications